Back
Halozyme Therapeutics Stock Predictions
Buy
75
HALO
Halozyme Therapeutics
Last Price:
44.73
Seasonality Move:
1.35%
7 Day Trial
ALL ACCESS PASS
$
7
Halozyme Therapeutics Stock Forecast
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 50.9% based on the past 19 years of stock performance.
- Halozyme Therapeutics has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
-
Is Halozyme Therapeutics Stock Undervalued?
The current Halozyme Therapeutics [HALO] share price is $44.71. The Score for HALO is 75, which is 50% above its historic median score of 50, and infers lower risk than normal. - HALO is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Halozyme Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Halozyme Therapeutics has on average historically risen by 50.9% based on the past 19 years of stock performance.
Halozyme Therapeutics Stock Rating
Buy
75
Halozyme Therapeutics (HALO)
is a Buy
Is Halozyme Therapeutics overpriced?
- Halozyme Therapeutics has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
Halozyme Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
halozyme.com
52-Week Data
52-Week High:
46.16
52-Week Low:
31.86
Prediction Charts
Market Cap:
5.69B
Price in USD:
44.71
Volume:
1.1M
Beta:
1.50
Technical Analysis
SMA50:
40.55
SMA100:
38.51
SMA200:
38.83
52-Wk Change:
33.62%
Stock Predictions
-
Is Halozyme Therapeutics stock public?
Yes, Halozyme Therapeutics is a publicly traded company. -
What is the Halozyme Therapeutics stock quote today?
The Halozyme Therapeutics stock price is 44.71 USD today. -
How to buy Halozyme Therapeutics stock online?
You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-30 | 38.54 | 38.11 | 39.03 | 37.97 |
May-1 | 38.40 | 39.30 | 40.00 | 38.30 |
May-2 | 39.56 | 39.82 | 40.74 | 38.88 |
May-3 | 40.67 | 39.91 | 40.74 | 39.79 |
May-6 | 40.36 | 40.86 | 40.97 | 40.19 |
May-7 | 41.10 | 41.27 | 41.66 | 40.87 |
May-8 | 41.95 | 42.01 | 44.79 | 41.43 |
May-9 | 42.20 | 43.86 | 43.93 | 41.28 |
May-10 | 44.08 | 43.15 | 44.21 | 43.12 |
May-13 | 43.49 | 43.61 | 44.01 | 43.36 |
May-14 | 44.03 | 43.82 | 45.18 | 43.55 |
May-15 | 44.26 | 45.82 | 46.05 | 44.01 |
May-16 | 45.86 | 45.39 | 46.16 | 45.22 |
May-17 | 45.36 | 44.71 | 45.76 | 44.35 |
Halozyme Therapeutics Earnings
Halozyme Therapeutics Earnings Report: Per Share Halozyme Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Halozyme Therapeutics Forecast Revenue Growth
Halozyme Therapeutics Stock Analysis: Historical quarterly revenues per share for Halozyme Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.30 per share, an increase next quarter of $0.05 per share, an increase this year of $0.85 per share, and an increase next year of $0.83 per share.
* Halozyme Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.